Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -204,149 | -623,506 | -595,625 | -823,605 | -213,090 |
| Depreciation Amortization | 207,229 | 213,527 | 200,556 | 376,123 | 45,387 |
| Income taxes - deferred | -955 | -11,901 | -253,169 | -6,748 | -193,605 |
| Accounts receivable | -43,416 | 61,088 | 25,150 | -100,526 | -27,633 |
| Accounts payable and accrued liabilities | 82,750 | -52,180 | 169,800 | 55,165 | 3,469 |
| Other Working Capital | -342 | -26,377 | 111,109 | -42,269 | -53,556 |
| Other Operating Activity | 115,002 | 215,790 | 239,943 | 678,342 | 327,373 |
| Operating Cash Flow | $156,119 | $-223,559 | $-102,236 | $136,482 | $-111,655 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 223,302 | 321,586 | -369,728 | -203,278 | 1,023,087 |
| PPE Investments | -124,690 | -189,462 | -193,839 | -476,499 | -172,654 |
| Net Acquisitions | -52,413 | -14,686 | -499,730 | -6,658 | -973,861 |
| Purchase Of Investment | -16,564 | -42,823 | -18,044 | -15,947 | N/A |
| Sale Of Investment | 19,794 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 250 | -549 | -744 | 345 | -1,000 |
| Investing Cash Flow | $49,679 | $74,066 | $-1,082,085 | $-702,037 | $-124,428 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 137,976 | 0 | 0 | 1,125,547 | 729,477 |
| Debt Repayment | N/A | N/A | N/A | -150,054 | -493,356 |
| Common Stock Issued | 31,541 | 32,015 | 37,507 | 907,133 | 17,183 |
| Other Financing Activity | -9,751 | 44,470 | -29,035 | -3,005 | -123 |
| Financing Cash Flow | $159,766 | $76,485 | $8,472 | $1,879,621 | $253,181 |
| Exchange Rate Effect | 1,321 | 30 | 23 | N/A | N/A |
| Beginning Cash Position | 242,790 | 315,768 | 1,491,594 | 177,528 | 160,430 |
| End Cash Position | 609,675 | 242,790 | 315,768 | 1,491,594 | 177,528 |
| Net Cash Flow | $366,885 | $-72,978 | $-1,175,826 | $1,314,066 | $17,098 |
| Free Cash Flow | |||||
| Operating Cash Flow | 156,119 | -223,559 | -102,236 | 136,482 | -111,655 |
| Capital Expenditure | -124,690 | -214,462 | -193,839 | -476,499 | -172,654 |
| Free Cash Flow | 31,429 | -438,021 | -296,075 | -340,017 | -284,309 |